Target Information
Evoralis is an innovative company developing cutting-edge enzymes capable of breaking down even the most complex and composite fibers, paving the way for a genuine circular economy in the textile sector. Founded as a spin-out of the Hollfelder Laboratory at the University of Cambridge, Evoralis specializes in the discovery and development of enzymes for the depolymerization of plastic materials.
The startup has recently secured £2.5 million in a Seed funding round, which marks a significant step toward fulfilling its mission of revolutionizing fabric recycling and other plastic waste management processes.
Industry Overview
The textile industry is currently facing critical challenges as global fiber production has nearly doubled over the past twenty years, reaching a staggering 109 million tons in 2023. A significant portion of this production is currently non-recyclable, presenting an urgent challenge in recovering mixed and composite fibers. In Europe alone, approximately 6 million tons of post-consumer textile waste is generated each year, with 60% of garments sold today containing fossil-fuel-derived plastic that existing recycling methods struggle to address.
Evoralis aims to tackle this pressing issue with its revolutionary enzymatic technology, which offers a viable solution for recycling over 80% of textile products, including those made from mixed and composite fibers containing plastic. This innovative approach enables the separation of various materials within fabrics and has the potential to create a market worth $560 billion.
Moreover, the company’s platform has already attracted attention from major fashion retailers who have engaged Evoralis to develop specific enzymes for recycling nylon and polyurethane—two of the most challenging synthetic polymers to recycle.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Rationale Behind the Deal
By securing this funding, Evoralis aims to enhance its enzymatic technology further, facilitating the recycling of textiles and plastics that were previously deemed non-recyclable. This investment not only supports the development of sustainable solutions but also aligns with the increasing demand for environmentally-friendly practices in the textile industry.
Investor Information
The funding round was spearheaded by LIFTT S.p.A and included co-investments from Cambridge Enterprise Ventures, Parkwalk Advisors, Backbone Ventures, and angel investors focusing on circular economy initiatives, such as Circular Plastics Accelerator and Archipelago Ventures. CPI successfully converted a loan into equity, acquiring stakes in the company as well.
Investors have expressed their strong confidence in Evoralis’ potential. Daniel Kaute, CEO of Evoralis, emphasized the importance of this funding in advancing the company's mission, while Edoardo Bianchi, Project Manager at LIFTT, highlighted the innovative technology’s ability to transform textile recycling methodologies.
View of Dealert
Investing in Evoralis presents a significant opportunity, given the growing urgency for sustainable practices in the textile industry. The company's unique enzymatic technology addresses a major pain point in the recycling challenge, potentially enabling a vast market for recycled materials. With increasing regulatory pressures and consumer demand for sustainable products, Evoralis is well-positioned to capitalize on these trends.
Additionally, the support from credible investors such as LIFTT and Cambridge Enterprise Ventures not only validates Evoralis' business model but also enhances its strategic positioning within the market. The involvement of fashion retailers seeking customized solutions further suggests a strong commercial interest in the technology, which can lead to beneficial partnerships.
However, the path to commercial success requires careful attention to scalability and operational execution. While the technology demonstrates significant promise, the company must navigate production challenges and market acceptance effectively. Continuous innovation and maintaining investor confidence will be crucial to realizing the long-term vision of transforming textile waste into a valuable resource.
In conclusion, Evoralis represents a compelling investment opportunity, potentially driving a shift toward a more sustainable textile industry while generating substantial financial returns.
Similar Deals
Cambridge Innovation Capital, SV Health Investors’ Dementia Discovery Fund, M Ventures, Pfizer Ventures → TRIMTECH Therapeutics
2025
ACF Investors → Monument Therapeutics
2025
AlbionVC and Spark Capital → Latent Technology
2025
LIFTT S.p.A
invested in
Evoralis
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $3M